Literature DB >> 31419569

Urgent Time to Allogeneic Hematopoietic Cell Transplantation: A National Survey of Transplant Physicians and Unrelated Donor Search Coordinators Facilitated by the Histocompatibility Advisory Group to the National Marrow Donor Program.

Joseph Pidala1, Tatenda G Mupfudze2, Tammy Payton3, Juliet Barker4, Miguel-Angel Perales4, Bronwen E Shaw5, Marcelo Fernández-Viña6, Linda J Burns2, Jason Dehn3.   

Abstract

To characterize donor search and selection practices, the National Marrow Donor Program (NMDP) Histocompatibility Advisory Group developed a survey of allogeneic hematopoietic cell transplant (HCT) physicians and search coordinators. The objectives were to describe search practices, understand practices surrounding urgent time to HCT, and characterize strategies used when identifying a matched unrelated donor is unlikely. Participants included US physician members of the American Society for Transplantation and Cellular Therapy and donor search coordinators within the NMDP network. The web-based survey was conducted from February to May 2018. Three hundred seventeen of 858 physicians (37%) and 225 of 327 coordinators (69%) responded, of which 263 and 194, respectively, were eligible and included in the analysis. Most centers, 142 (95%), were represented; 108 (72%) had at least 1 physician and 128 (85%) had at least 1 coordinator respondent. Most (68% physicians, 61% coordinators) indicated donor selection decisions were made by individual physicians. Urgent time to HCT was most commonly (90% and 87% of physicians and coordinators, respectively) defined as HCT within 4 to 6 weeks of search initiation. Higher HCT urgency was associated with a higher disease risk index. For urgent cases with low probability of an 8/8 matched unrelated donor , 75% and 80% of physicians and coordinators endorsed a short (1 to 2 weeks) unrelated donor search before proceeding to an alternative donor source. NMDP-provided solutions to expedite donor identification were strongly endorsed. This survey clarified current donor selection practices in the United States and defined urgent time to HCT. These data provide insight to NMDP on potential solutions to support the path to transplant, such as highlighting futile searches and providing alternative donor options at the time of search initiation.
Copyright © 2019. Published by Elsevier Inc.

Entities:  

Keywords:  Allogeneic donors; Allogeneic hematopoietic cell transplantation; Donor selection; National Marrow Donor Program; Urgent time to transplant

Mesh:

Year:  2019        PMID: 31419569      PMCID: PMC7307219          DOI: 10.1016/j.bbmt.2019.08.002

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  9 in total

1.  Unrelated donor search prognostic score to support early HLA consultation and clinical decisions.

Authors:  K Wadsworth; M Albrecht; R Fonstad; S Spellman; M Maiers; J Dehn
Journal:  Bone Marrow Transplant       Date:  2016-06-06       Impact factor: 5.483

2.  How to improve the search for an unrelated haematopoietic stem cell donor. Faster is better than more!

Authors:  M B A Heemskerk; S M van Walraven; J J Cornelissen; R M Y Barge; R G M Bredius; R M Egeler; J L W Tj Lie; T Révész; K Sintnicolaas; N M Wulffraat; A E Donker; P M Hoogerbrugge; J J van Rood; F H J Claas; M Oudshoorn
Journal:  Bone Marrow Transplant       Date:  2005-04       Impact factor: 5.483

3.  HapLogic: A Predictive Human Leukocyte Antigen-Matching Algorithm to Enhance Rapid Identification of the Optimal Unrelated Hematopoietic Stem Cell Sources for Transplantation.

Authors:  Jason Dehn; Michelle Setterholm; Kelly Buck; Jane Kempenich; Beth Beduhn; Loren Gragert; Abeer Madbouly; Stephanie Fingerson; Martin Maiers
Journal:  Biol Blood Marrow Transplant       Date:  2016-08-02       Impact factor: 5.742

4.  The National Marrow Donor Program's symposium on patient advocacy in cellular transplantation therapy: addressing barriers to hematopoietic cell transplantation.

Authors:  Elizabeth A Murphy; Stacy Stickney Ferguson; Nancy Atieno Omondi; Lisa C Getzendaner; James L Gajewski; Gary A Goldstein; John R Wingard; J Douglas Rizzo; Navneet S Majhail; Navneet S Mahjail
Journal:  Biol Blood Marrow Transplant       Date:  2009-09-30       Impact factor: 5.742

5.  Validation of an Algorithm to Predict the Likelihood of an 8/8 HLA-Matched Unrelated Donor at Search Initiation.

Authors:  Eric Davis; Sean Devlin; Candice Cooper; Melissa Nhaissi; Jennifer Paulson; Deborah Wells; Andromachi Scaradavou; Sergio Giralt; Esperanza Papadopoulos; Nancy A Kernan; Courtney Byam; Juliet N Barker
Journal:  Biol Blood Marrow Transplant       Date:  2017-12-26       Impact factor: 5.742

6.  Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation.

Authors:  Philippe Armand; Haesook T Kim; Brent R Logan; Zhiwei Wang; Edwin P Alyea; Matt E Kalaycio; Richard T Maziarz; Joseph H Antin; Robert J Soiffer; Daniel J Weisdorf; J Douglas Rizzo; Mary M Horowitz; Wael Saber
Journal:  Blood       Date:  2014-04-17       Impact factor: 22.113

7.  HLA match likelihoods for hematopoietic stem-cell grafts in the U.S. registry.

Authors:  Loren Gragert; Mary Eapen; Eric Williams; John Freeman; Stephen Spellman; Robert Baitty; Robert Hartzman; J Douglas Rizzo; Mary Horowitz; Dennis Confer; Martin Maiers
Journal:  N Engl J Med       Date:  2014-07-24       Impact factor: 91.245

8.  Race/ethnicity affects the probability of finding an HLA-A, -B, -C and -DRB1 allele-matched unrelated donor and likelihood of subsequent transplant utilization.

Authors:  J Pidala; J Kim; M Schell; S J Lee; R Hillgruber; V Nye; E Ayala; M Alsina; B Betts; R Bookout; H F Fernandez; T Field; F L Locke; T Nishihori; J L Ochoa; L Perez; J Perkins; J Shapiro; C Tate; M Tomblyn; C Anasetti
Journal:  Bone Marrow Transplant       Date:  2012-08-06       Impact factor: 5.483

Review 9.  Access to hematopoietic cell transplantation in the United States.

Authors:  Navneet S Majhail; Nancy A Omondi; Ellen Denzen; Elizabeth A Murphy; J Douglas Rizzo
Journal:  Biol Blood Marrow Transplant       Date:  2009-12-28       Impact factor: 5.742

  9 in total
  3 in total

1.  Improving the turnaround times of infectious disease markers reporting in an NHS stem cell department.

Authors:  Ying Li; Nathan Proudlove
Journal:  BMJ Open Qual       Date:  2022-06

2.  Optimal Donor Selection for Hematopoietic Cell Transplantation Using Bayesian Machine Learning.

Authors:  Brent R Logan; Martin J Maiers; Rodney A Sparapani; Purushottam W Laud; Stephen R Spellman; Robert E McCulloch; Bronwen E Shaw
Journal:  JCO Clin Cancer Inform       Date:  2021-05

3.  Likelihood of Proceeding to Allogeneic Hematopoietic Cell Transplantation in the United States after Search Activation in the National Registry: Impact of Patient Age, Disease, and Search Prognosis.

Authors:  Jason Dehn; Pintip Chitphakdithai; Bronwen E Shaw; Abby A McDonald; Steven M Devine; Linda J Burns; Stephen Spellman
Journal:  Transplant Cell Ther       Date:  2020-10-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.